Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease
β Scribed by K. Nakashima; M. Shimoda; N. Kuno; K. Takahashi
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 437 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
To the Editor:
The list of drugs that can induce parkinsonism has recently increased. Marti Mass6 et al. (1) emphasized the awareness of the possibility of inducing parkinsonism and the avoidance of certain drugs in patients with Parkinson's disease. Some patients with drug-induced parkinsonism caused by calcium antagonists have been reported (2-6). Manidipine hydrochloride, which has been developed and registered in Japan, is one of the new calcium channel blockers. We have experienced two cases of worsening parkinsonian symptoms after the use of manidipine, with improvements observed following the withdrawal of manidipine.
π SIMILAR VOLUMES
roradiological features beyond the typical cerebellar peduncle hyperintensities that were found minimal in this instance. FXTAS is expected to be less severe in females because of the presence of two X chromosomes, subject to random inactivation. It has been suggested that expression of the disease
## Abstract Deep brain stimulation of the subthalamic nucleus (STNβDBS) is an established therapy for Parkinson's disease (PD). A manic episode with psychotic symptoms induced by STNβDBS occurred in a previously psychiatrically healthy patient, focusing on the role of STNβDBS in influencing not onl